Evolución y desarrollo de complejos metálicos con aplicación potencial como agentes antitumorales

SG Ruiz - Anales de Química de la RSEQ, 2010 - analesdequimica.es
El presente artículo trata de hacer un breve repaso sobre la evolución, desarrollo de la
estructura y acción celular de algunos derivados metálicos con actividad anticancerosa. Se …

[PDF][PDF] Development of radionuclide generators for biomedical applications

R Chakravarty - (No Title), 2011 - hbni.ac.in
In the recent times, nanoparticles, or objects of size in the range of nanometer (1-100 nm)
have become one of the most exciting objects of investigation and have played important …

Optimization of hapten-peptide labeling for pretargeted immunoPET of bispecific antibody using generator-produced 68Ga

H Karacay, RM Sharkey, WJ McBride… - Journal of nuclear …, 2011 - Soc Nuclear Med
Bispecific antibody pretargeting is highly sensitive and specific for cancer detection by PET.
In this study, the preparation of a high-specific-activity 68Ga-labeled hapten-peptide …

α (N)-Heterocyclic thiosemicarbazones: iron chelators that are promising for revival of gallium in cancer chemotherapy

S Cao, X Chen, L Chen, J Chen - Anti-Cancer Agents in …, 2016 - ingentaconnect.com
The metal-based drugs have gained increasing attention in the fight against cancer. Ga (III)
in the form of inorganic salts has demonstrated efficacy in the treatment of a number of …

Four-coordinate dimethylgallium compounds vary in stability toward hydrolysis

RW Chesnut, RR Cesati, CS Cutler, SL Pluth… - …, 1998 - ACS Publications
Four-coordinate dimethylgallium complexes were prepared by the reaction of
dimethylgallium hydroxide with bidentate Lewis bases and evaluated for their stability …

Metal radionuclides for PET imaging

P McQuade, DW McCarthy, MJ Welch - Positron Emission Tomography …, 2005 - Springer
Conclusions There are many possible metal-based positron-emitting radionuclides that can
be utilized in positron tomography. At the present time, the most promising nuclides are …

Development of 153Sm-DTPA-rituximab for radioimmunotherapy

A Bahrami-Samani, M Ghannadi-Maragheh… - Nukleonika, 2009 - infona.pl
Combining beta-particle effect with therapeutic properties of anti-CD20 monoclonal antibody
in lymphomas, Mabthera™(rituximab) was targeted in this study. The antibody was labeled …

Synthesis, characterization and solid state structure of a neutral gallium (III) amino thiolate complex: a potential radiopharmaceutical for PET imaging

LC Francesconi, BL Liu, JJ Billings, PJ Carroll… - Journal of the …, 1991 - pubs.rsc.org
Synthesis, Characterization and Solid State Structure of a Neutral Gallium(iii) Amino Thiolate
Complex: A Potential Radiopharmac Page 1 94 J. CHEM. SOC., CHEM. COMMUN., 1991 …

1-n-Propyl- and 1-n-butyl-3-hydroxy-2-methyl-4-pyridinone complexes of group 13 (IIIA) metal ions

L Simpson, SJ Rettig, J Trotter… - Canadian journal of …, 1991 - cdnsciencepub.com
On a préparé et caractérisé les complexes tricoordinés de l'aluminium, du gallium et de
l'indium avec la 3-hydroxy-2-méthyl-1-n-popyl-pyridin-4-one et la 1-n-butyl-3-hydroxy-2 …

Preparation and biodistribution of [111In]-rHuEpo for erythropoietin receptor imaging

H Sadeghpour, AR Jalilian, M Akhlaghi… - … of radioanalytical and …, 2008 - Springer
Human recombinant erythropoietin (EPO) was successively labeled with [111 In]-indium
chloride after conjugation with freshly prepared cyclic DTPA-dianhydride (ccDTPA). The best …